Massive gene hunt launched for mysterious mitochondrial diseases
NCT ID NCT01803906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to discover new genetic mutations that cause mitochondrial disorders by analyzing tissue samples from up to 6,900 participants. It includes people with suspected or known mitochondrial diseases, such as MELAS or Leigh's Disease, who lack a genetic diagnosis. The research focuses on measuring respiratory chain enzyme levels and identifying new mutations, but does not offer any treatment or direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KEARNS SAYER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Worldwide data pool could pave the way for mitochondrial disease trials
- MNGIE patients needed to map disease course and speed up future treatments
- Massive genetic study aims to unlock secrets of rare metabolic diseases
- New study aims to unlock why infections hit mitochondrial disease patients hard
- New DNA test could end years of uncertainty for mitochondrial disease patients
- Mini muscle sensor could unlock mitochondrial disease diagnosis